Kenneth Allen Myszkowski - Net Worth and Insider Trading
Kenneth Allen Myszkowski Net Worth
The estimated net worth of Kenneth Allen Myszkowski is at least $10 Million dollars as of 2024-06-08. Kenneth Allen Myszkowski is the CFO of Arrowhead Pharmaceuticals Inc and owns about 400,600 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $10 Million. Details can be seen in Kenneth Allen Myszkowski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth Allen Myszkowski has not made any transactions after 2024-03-06 and currently still holds the listed stock(s).
Transaction Summary of Kenneth Allen Myszkowski
Kenneth Allen Myszkowski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Allen Myszkowski owns 1 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) .
Click here to see the complete history of Kenneth Allen Myszkowski’s form 4 insider trades.
Insider Ownership Summary of Kenneth Allen Myszkowski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2024-03-06 | CFO |
Kenneth Allen Myszkowski Latest Holdings Summary
Kenneth Allen Myszkowski currently owns a total of 1 stock. Kenneth Allen Myszkowski owns 400,600 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of March 6, 2024, with a value of $10 Million.
Latest Holdings of Kenneth Allen Myszkowski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARWR | Arrowhead Pharmaceuticals Inc | 2024-03-06 | 400,600 | 23.91 | 9,578,346 |
Holding Weightings of Kenneth Allen Myszkowski
Kenneth Allen Myszkowski Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Allen Myszkowski has made a total of 12 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 40,000 shares on March 6, 2024, which brought Kenneth Allen Myszkowski around $1 Million.
Insider Trading History of Kenneth Allen Myszkowski
- 1
Kenneth Allen Myszkowski Trading Performance
Kenneth Allen Myszkowski Ownership Network
Kenneth Allen Myszkowski Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Kenneth Allen Myszkowski is the CFO of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include other: Senior Vice President James C Hamilton , director & President and CEO Christopher Richard Anzalone , and Chief Medical Officer Martin Javier San .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Kenneth Allen Myszkowski made 4 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 101,729. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 266,472 shares made by Christopher Richard Anzalone , a net sale of 79,524 shares made by James C Hamilton , and a net sale of 65,690 shares made by Patrick O'brien .
In summary, during the past 3 months, insiders sold 7,799 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 3,000 shares, with a net sale of 4,799 shares. During the past 18 months, 590,403 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 587,403 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Kenneth Allen Myszkowski Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Allen Myszkowski. You might contact Kenneth Allen Myszkowski via mailing address: Arrowhead Research Corporation, 201 South Lake Avenue, Suite 703, Pasadena Ca 91101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
